BMAC – Biopharmaceutical Manufacturer's Advisory Council
An initiative by leading Biopharmaceutical companies in the world to establish Singapore as the country of choice for global biomedical sciences manufacturing.
At Takeda Singapore Manufacturing site, the Training Dept has AR (Augmented Reality) for an immersive training experience to enhance our people’s capability. The first module is on the column assembly and disassembly in the manufacturing suite. Due to the lack of opportunity for hands-on training, and it being an infrequent process, this AR module allows operators to practice with digital instructions and viewing the equipment in both AR and 3D mode during operations. We have now also adopted HoloLens to enable a hands-free operation (see video demo).
Our R&D engine has produced exciting new molecular entities (NMEs) across our core Therapeutic Areas: Oncology, Rare Genetic and Hematology, Neuroscience, and Gastroenterology.
Takeda has made environmental efforts and its commitment to carbon zero by 2040 a priority.